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Abstract 1 
The current diagnostic standard procedure outlined by the HPA for urinary tract 2 
infections (UTI) in clinical laboratories does not report bacteria isolated from 3 
samples containing 3 or more different bacterial species. As a result many UTI go 4 
unreported and untreated, particularly in elderly patients, where polymicrobial UTI 5 
samples are especially prevalent.  This study reports the presence of the major 6 
uropathogenic species in mixed culture urine samples from elderly patients, and 7 
of resistance to front line antibiotics, with potentially increased levels of 8 
resistance to ciprofloxacin and trimethoprim. Most importantly, the study 9 
highlights that E. coli present in polymicrobial UTI samples are statistically more 10 
invasive (P < 0.001) in in vitro epithelial cell infection assays than those isolated 11 
from monomicrobial culture samples. In summary this study suggests that the 12 
current diagnostic standard procedure for polymicrobial UTI samples needs to be 13 
re-assessed, and that E. coli present in polymicrobial UTI samples may pose an 14 
increased risk to human health.  15 
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3 
Introduction 19 
The annual incidence of UTI in the elderly population ranges from 10% in the 20 
community to as high as 30% of hospitalised patients (Cove-Smith & Almond, 21 
2007).  Mortality rates in elderly patients from bacteraemia as a result of UTI can 22 
be as high as 33% (Tal et al., 2005). A study by Plowman et al. (2001) found that 23 
over a 12-month period urinary tract infections had the highest incidence (35%) 24 
of all nosocomial infections in a district general hospital, and the majority of 25 
patients were over 60 years of age. UTI are also the most common infection in 26 
long term care facilities, where they account for 20-60% of all antibiotic 27 
prescriptions (Nicolle, 2001a). This large-scale prescription of antibiotics may well 28 
contribute to the levels of antibiotic resistance in urinary pathogens (Zhanel et al., 29 
2005). The main etiologic agent of UTI is well documented as E. coli (Nicolle et 30 
al., 2001b, Farajnia et al., 2008, & Kumazawa & Matsumoto, 1997). The 31 
establishment of urinary tract pathogens is thought to begin with the invasion of 32 
the superficial bladder epithelium, where bacteria can form intracellular 33 
communities and receive a level of protection against the host immune system 34 
and antibiotic treatment (Anderson et al., 2003, Blango & Mulvey, 2010).  35 
The diagnosis of UTI is routinely performed in the clinical laboratory by 36 
microbiological culture of a urine sample according to the national standard 37 
method developed and approved by the Health protection Agency  38 
(http://www.hpa-standardmethods.org.uk/documents/bsop/pdf/bsop41.pdf).  39 
Infections caused by a single organism are usually treatable with an antibiotic 40 
regimen advised on the basis of antibiotic susceptibility tests. However, it has 41 
been estimated that 33% of urine cultures from elderly patients are polymicrobial 42 
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(Cove-Smith & Almond, 2007). Due to the difficulties of identifying the organisms 43 
present in these cultures clinical microbiology laboratories do not report 44 
organisms isolated from urine in mixed culture unless there is a significant count 45 
of a predominant organism  46 
As a result there is insufficient information on the bacteria that cause 47 
polymicrobial UTI and the threat they pose to patient health. This study aimed to 48 
isolate the organisms present in polymicrobial urinary tract infection samples 49 
from a population of elderly patients, and compare their prevalence, phenotypic 50 
activity and pathogenic potential to monomicrobial culture isolates from the same 51 
population, with the aim of further understanding the potential threat posed by 52 
bacteria present in polymicrobial urine samples from elderly patients, and 53 
possibly reassessing the current diagnostic standard procedure.  54 
 55 
Materials and Methods 56 
 57 
Sample collection 58 
Two hundred and fifty urine culture agar plates were collected from Nottingham 59 
University Hospitals (NUH) between October 2008 and June 2009. Cultures were 60 
collected anonymously (therefore no ethical approval or informed consent 61 
required) from patients aged 70 and over and assigned to one of the following 62 
categories; (1) non-catheterized male polymicrobial infection, (2) non-63 
catheterized female polymicrobial infection, (3) catheterized male polymicrobial 64 
infection, (4) catheterized female polymicrobial infection, all of which contained 3 65 
or more organisms with no predominant count of one species. A fifth group, 66 
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monomicrobial infection (uncatheterized or catheterized, males or females), was 67 
also included for use as a control group. Bacteria were isolated using standard 68 
microbiological identification procedures. Identification of isolates to species level 69 
was performed using the API identification systems, API 20E, API 20strep, API 70 
20NE and API Staph (Biomerieux,).  71 
Antibiotic susceptibility testing 72 
A breakpoint method was employed to obtain antibiotic susceptibility profiles for 73 
all E. coli, S. aureus, E. faecalis and P. mirabilis. The BSAC method for 74 
antimicrobial susceptibility testing was followed to prepare standardised inocula 75 
(Andrews, 2009). The antibiotic panel used was as follows; Gentamicin (2µg/ml), 76 
Cefotaxime (1 µg/ml), Ceftazidime (1 µg/ml), Meropenem (2 µg/ml), Piperacillin-77 
tazobactam (16 µg/ml), Co-amoxiclav (32 µg/ml), Trimethoprim (2 µg/ml), 78 
Ciprofloxacin (4 µg/ml), Cephradine (32 µg/ml), Nitrofurantoin (32 µg/ml), and 79 
Amoxicillin (32 µg/ml). All P. aeruginosa isolates were tested using the BSAC 80 
disc diffusion method (Andrews, 2009) and an antibiotic panel specific to 81 
Pseudomonas; Gentamicin (10µg/ml), Piperacillin-tazobactam (85 µg/ml), 82 
Ceftazidime (30 µg/ml), Meropenem (10 µg/ml) and Ciprofloxacin (1 µg/ml).  83 
PCR detection of β-lactamase genes 84 
All E. coli, Klebsiella, Proteus, Pseudomonas, Enterobacter and Citrobacter 85 
isolates were tested for the presence of the β-lactamase genes, blaTEM, blaSHV, 86 
blaCTX-M and blaOXA using a previously described multiplex PCR (Fang et al., 87 
2008). GenElute extraction kits (SIGMA) were used to extract bacterial genomic 88 
DNA. Reference strains containing known β-lactamase types (NCTC 13351 E. 89 
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coli blaTEM-3, NCTC 13353 E. coli blaOXA, blaCTX-M-15, and blaTEM and NCTC 13368 90 
Klebsiella pneumoniae blaTEM, blaSHV-18) were included as controls.  91 
ESBL confirmation tests 92 
ESBL combination ID discs were used to confirm the extended spectrum activity 93 
of selected β-lactamase positive strains. The BSAC method for antimicrobial 94 
susceptibility testing (Andrews, 2009) was followed to prepare a standardised 95 
inoculum, which was used to inoculate an Iso-Sensitest agar plate to produce a 96 
lawn of growth. Two sets of combination discs were used to optimise ESBL 97 
detection, Cefpodoxime/Cefpodoxime&clavulanate and 98 
Cefepime/Cefepime&clavulanate. An increase in zone of inhibition diameter of 99 
≥5mm of the cephalosporin/clavulanic acid disc compared to the cephalosporin 100 
alone indicated the presence of an ESBL-producing organism. Reference 101 
organisms E. coli NCTC 13351, E. coli NCTC 13352 and E. coli NCTC 13353 102 
and E. coli NCTC 10418 (HPA culture collections) were used for control 103 
purposes. 104 
Detection of vancomycin resistant enterococci, MRSA and Panton-105 
Valentine Leukocidin producing S. aureus 106 
A previously published protocol, (Jayaratne et al., 1999) was used to screen all 107 
E. faecalis and E. faecium isolates for the presence of vanA and vanB genes. 108 
GenElute extraction kits (SIGMA) were used to extract bacterial genomic DNA. E. 109 
faecalis NCTC 12201 was used as a reference strain.  110 
A real-time PCR protocol developed by Thomas et al, (2007) was used to detect 111 
the presence of the mecA gene, which confers resistance to methicillin, in all 112 
Staphylococcus aureus isolates. PCR was also performed for the detection of the 113 
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PVL-encoding gene, lukF, using a previously published protocol (Ribeiro et al., 114 
2005). The BSAC disc diffusion protocol (Andrews, 2009) was followed to test all 115 
S. aureus isolates for phenotypic resistance to cefoxitin, which is indicative of 116 
methicillin resistance, and a selection of Enterococcus isolates for phenotypic 117 
resistance to vancomycin.  118 
BOX-PCR 119 
To confirm the organisms isolated from the UTI cultures were not all related to a 120 
single locally disseminated clone, BOX-PCR was performed using a protocol 121 
adapted from that of Koeuth et al, (1995). Extraintestinal pathogenic Escherichia 122 
coli (ExPEC) CFT073 was used as a reference strain. PCR products were 123 
examined using bionumerics software (BioNumerics v.3.5, Applied Maths), using 124 
CFT073 to monitor the repeatability of the experiment. 125 
Cell cultures 126 
T24 human epithelial cells (HPA cultures) were grown in McCoy’s 5A modified 127 
media (Sigma, UK) supplemented with 10% fetal bovine serum (Sigma, UK) and 128 
0.75% L-glutamine (Sigma, UK). Cells were grown in an atmosphere with 5% 129 
CO2 at 37oC and sub-cultured twice-weekly. Two days prior to cell infection 130 
assays, the T24 cells were seeded into 24-well plates 131 
Association and invasion assays 132 
All E. coli assays were performed in duplicate on different days, and in triplicate 133 
wells in each assay. Bacteria were cultured overnight in LB broth, harvested by 134 
centrifugation and re-suspended in supplemented tissue culture medium, which 135 
was then adjusted to 2x107 cfu/ml, giving an MOI of 1:100. For E. coli, all 129 136 
polymicrobial ExPEC and 21 monomicrobial ExPEC isolated in this study were 137 
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quantifiably assayed using classical gentamicin protection assays as described 138 
previously (McNally et al., 2007), using cultured T24 bladder cells. The invasive 139 
ExPEC type strain, CFT073 was used as a positive control strain in all assays 140 
and E.coli DH5α was used as a negative control strain. The mean number of 141 
invasive bacteria was determined by Miles & Misra plate counts from triplicate 142 
wells. Strains that showed more than a 10-fold increase in invasion compared to 143 
CFT073 were classed as highly-invasive strains. Those that showed more than a 144 
10-fold decrease in invasion compared to CFT073 were deemed to be strains of 145 
limited invasive potential.  146 
All E. faecalis, P. mirabilis, P. aeruginosa and S. aureus were subjected to a 147 
semi-quantitative screen performed in triplicate on different days to assess levels 148 
of invasion. Assays were completed using the above method, which was adapted 149 
for 96-well plates as described by Javed et al, (2009). 150 
Statistical analysis 151 
χ 2 tests were performed to compare invasion and antimicrobial resistance 152 
between the monomicrobial culture and mixed culture populations, and also 153 
bacterial prevalence in different patient groups. 154 
 155 
Results 156 
Similar bacterial species are isolated from monomicrobial and 157 
polymicrobial UTI samples  158 
Urine culture plates were collected from 250 patients over a 9-month period from 159 
Nottingham University Hospitals (NUH) and were taken from both hospitalised 160 
and community patients, with the median age of patients being 83.5 years. Of the 161 
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200 polymicrobial cultures collected, 71 (36%) contained 2 organisms, 90 (45%) 162 
contained 3 organisms, 36 (18%) contained 4 organisms and 3 (1%) contained 5 163 
organisms. Eighty three patients (33%) had previous history of UTI, 27 cases of 164 
which were designated as ‘mixed’ by the NUH clinical laboratory. Of these 27 165 
patients presenting with a polymicrobial UTI, 13 went on to have further 166 
incidences of polymicrobial UTI after this study, 5 patients went on to have a UTI 167 
sample with a confirmed organism in monomicrobial culture and 9 had no further 168 
infections. 169 
A total of 620 bacterial strains were isolated from the 250 urine cultures and 170 
identified to species level using API identification systems (figure 1). The most 171 
predominant organism in both catheterised and uncatheterised patients was E. 172 
coli, which was also far more prevalent in female patient cultures (83%) than 173 
male cultures (46%) P<0.001. In male samples E. faecalis was equally as 174 
ubiquitous as E. coli. These two organisms were also frequently associated in 175 
mixed cultures (36%). E. coli was isolated from 68% of polymicrobial cultures and 176 
48% of monomicrobial cultures, and E. faecalis was isolated from 55% of 177 
polymicrobial cultures, but was significantly less frequently isolated from 178 
monomicrobial cultures (8%), P<0.001. P. aeruginosa, P. mirabilis and S. aureus 179 
were also frequently isolated from 23%, 25% and 10.5% of polymicrobial cultures 180 
respectively.  181 
 BOX-PCR profiles provide evidence of a genetically diverse population 182 
In order to ensure that the organisms isolated were not epidemic clones, clonal 183 
relatedness of E. coli, E. faecalis, P. mirabilis, P. aeruginosa and S. aureus 184 
isolates was determined by BOX–PCR. BOX-group numbers were allocated 185 
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based upon a similarity threshold of 92% which was decided upon after reviewing 186 
previous publications (Proudy et al., 2008, & Yang et al., 2004). The E.  coli 187 
strains exhibited varying BOX-profiles (figure 2) and did not appear to belong to a 188 
dominant epidemic clone. Nineteen distinct clonal groups of E. coli were 189 
assigned, the largest of which encompassed 71 of the total 150 E. coli strains in 190 
the collection. Eleven distinct BOX-groups of E. faecalis were detected, with the 191 
majority of isolates belonging to 2 of the groups, group 1 containing 53 isolates 192 
and group 3 containing 37 isolates. Eighteen of the 51 P. aeruginosa isolates 193 
were deemed to belong to the same BOX-group, and other isolates were also 194 
allocated to 11 other BOX-groups. P. mirabilis were allocated 5 BOX-groups in 195 
total, with 88% of strains found to belong to a single BOX-group. S. aureus were 196 
allocated to 7 BOX-groups with 50% of the total strains belonging to one group. 197 
These results suggest that the isolates are not derived from a single epidemic 198 
clone of each species, and are indeed individual strains which could reasonably 199 
be expected to possess varying phenotypic and genotypic properties.  200 
Antibiotic resistance is comparable between bacteria from mixed and 201 
monomicrobial cultures 202 
To determine the specific antibiotic resistances within the population of 203 
polymicrobial UTI organisms, 394 isolates of the 5 most commonly isolated 204 
species (E. coli, E. faecalis, P. aeruginosa, P. mirabilis and S. aureus) were 205 
subjected to antibiotic susceptibility tests using an antibiotic panel presently used 206 
in the NUH clinical laboratory (table 1). Results suggest that bacteria isolated 207 
from mixed culture samples exhibit comparable levels of resistance to front line 208 
antibiotics as that observed in isolates from monomicrobial culture samples, 209 
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regardless of species. With respect to E. coli, the percentage of mixed culture 210 
sample isolates exhibiting resistance to ciprofloxacin and trimethoprim was 211 
higher than that observed in monomicrobial culture sample isolates, and also 212 
higher than the levels observed routinely in clinical urinary tract infection isolates. 213 
The differences observed in this study are not statistically significant but require 214 
further specific investigation. 215 
Increased detection of Extended Spectrum β-Lactamases in monomicrobial 216 
culture isolates 217 
Due to the increasing prevalence of extended-spectrum β-lactamases (ESBLs) in 218 
clinical samples the UTI isolates were screened both for the possession of β-219 
lactamase genes and also for any ESBL phenotypic activity. All E. coli, 220 
Enterobacter, Citrobacter, Klebsiella, Proteus and Pseudomonas strains (n=355) 221 
were screened for the presence of blaTEM, blaSHV, blaCTX-M, and blaOXA genes 222 
using a previously published protocol (Fang et al., 2008). Forty-nine percent of 223 
strains were found to possess a β-lactamase gene, and one fifth of the strains 224 
possessed multiple bla genes (table 2). Interestingly most of the strains 225 
containing multiple β-lactamases originated from monomicrobial culture 226 
infections (P=0.009). Klebsiella species were found to possess the most β-227 
lactamases (93% positive), 61% of E. coli also possessed a form of β-lactamase 228 
and 12% possessed multiple β-lactamase genes. The extended spectrum β-229 
lactamase, CTX-M was found significantly more frequently in monomicrobial 230 
culture isolates than in isolates from polymicrobial infections (P=0.014). To 231 
determine phenotypic expression of extended spectrum resistance against β-232 
lactam antibiotics the double-disc method was used to screen all 173 β-233 
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lactamase PCR positive strains. Sixteen strains (9%) exhibited phenotypic ESBL 234 
activity (12 E. coli, 3 Pseudomonas and 1 Enterobacter), most of which was in 235 
strains that possessed multiple -lactamase genes, making it impossible to 236 
identify the β-lactamase gene responsible for the extended spectrum resistance.  237 
Detection of MRSA and PVL-producing S. aureus in polymicrobial UTI 238 
samples 239 
PCR detection of the mecA gene, confirmed 10 (45%) of the urinary S. aureus 240 
isolates to be MRSA. One of these was isolated from a monomicrobial culture 241 
UTI, and the remaining 9 confirmed MRSA were isolated from polymicrobial UTI 242 
samples. Phenotypic resistance tests confirmed all PCR MRSA strains to be 243 
resistant to cefoxitin, which is an indicator of methicillin resistance. The lukF 244 
gene, which encodes PVL production was detected in 2 methicillin sensitive S. 245 
aureus (MSSA) strains, which were both isolated from polymicrobial UTI 246 
samples. No vancomycin resistance genes were found in any of the E. faecalis 247 
isolates, but vanA was found in one E. faecium isolate. This isolate did not 248 
however show any phenotypic resistance to vancomycin. 249 
Bacteria isolated from polymicrobial UTI samples exhibit increased 250 
pathogenic potential in in vitro cell invasion assays.  251 
The ability to invade host epithelial cells is a critical factor in UTI. Therefore all E. 252 
coli, E. faecalis, P. aeruginosa, P. mirabilis and S. aureus strains were 253 
investigated to determine their ability to invade a human uroepithelial cell line. 254 
T24 human bladder cells were infected with a bacterial culture for 3 hours, after 255 
which external bacteria were killed by the addition of gentamicin and internalised 256 
bacteria were enumerated. In the case of the E. coli assays, strains were 257 
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designated as highly invasive if they showed a 10-fold increase in invasiveness 258 
compared to that of the invasive reference strain, E. coli CFT073, which exhibited 259 
variation of less than 1 log across all assays performed (less than 10 fold). 260 
Overall 52 strains (34.7%) were seen to exhibit the highly invasive phenotype 261 
and 21 strains (14%) exhibited a low invasive phenotype, more than a 10 fold 262 
reduction in invasion compared to that of CFT073. E. coli isolates from mixed 263 
culture samples exhibited increases in invasion as great as 1000 fold higher than 264 
that observed in the invasive type strain CFT073. No invasive capacity was 265 
observed in five strains, of which three were isolated from monomicrobial culture 266 
samples where they were reported as the infectious agent. Overall 45% of the 267 
polymicrobial E. coli strains assayed invaded to a similar level (less than a ten-268 
fold increase or decrease) as that of CFT073 (figure 3). This is not significantly 269 
different to the monomicrobial culture isolates, 62% of which showed similar 270 
invasion capability to CFT073. In contrast 44% of polymicrobial E. coli strains 271 
were highly invasive, whereas no monomicrobial culture isolates invaded to a 272 
greater level than CFT073 and 11% of polymicrobial isolates were classified as 273 
‘low invasive’ compared to 38% of monomicrobial culture isolates. This suggests 274 
that E. coli isolated from polymicrobial UTI samples may be significantly more 275 
invasive (P<0.001, χ 2 distribution of strains with high, normal, and low invasive 276 
capacity across polymicrobial and monomicrobial populations) in an in vitro 277 
uroepithelial cell infection model, than E. coli isolated as monomicrobial cultures 278 
from UTI samples. No association could be found between invasiveness and 279 
patient gender, previous history of UTI, catheterisation status, health status of 280 
patient, antibiotic resistance profile or BOX-PCR group.  281 
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Invasion assays were also performed on all E. faecalis, P. mirabilis, P. 282 
aeruginosa and S. aureus isolates. A wide range in invasion capability was noted 283 
in E. faecalis isolates, ranging from 106cfu/ml to 102cfu/ml bacteria recovered 284 
from invasion assays. P. mirabilis, P. aeruginosa and S. aureus showed a similar 285 
trend with a 3-log range in invasion. Similarly the increased/decreased invasion 286 
levels are not attributable to any patient characteristic, antibiotic resistance profile 287 
or BOX-PCR group. 288 
 289 
Discussion 290 
Urinary tract infection rates in elderly people in the community can be as high as 291 
10% at any one time, and this figure can rise to 30% of hospitalised patients. 292 
Bacteraemic UTI in elderly patients can result in sepsis and death (Cove-Smith & 293 
Almond, 2007). A clinical microbiology laboratory will not routinely pursue or 294 
report organisms present in mixed culture from urine samples unless there is a 295 
significant count of a predominant organism. As up to 33% of samples can be 296 
polymicrobial a large proportion of infections from the elderly population may go 297 
untreated or indeed be treated with inappropriate antibiotics. This will only serve 298 
to encourage the development of antibiotic resistance in urinary pathogens.  299 
The predominant organism in polymicrobial UTI samples was E. coli, which 300 
concurs with the general consensus among previously published data concerning 301 
monomicrobial culture UTI (Farajnia et al., 2008, Tal et al., 2005, Johnson, 1991, 302 
& Brzuszkiewicz et al., 2006). E. faecalis was the second most commonly 303 
isolated organism, and was significantly more prevalent in polymicrobial cultures 304 
than monomicrobial cultures (P<0.001). E. faecalis and E. coli were found 305 
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together in 36% of cultures and co-infection by these two pathogens may pose 306 
important questions for the antibiotic treatment of polymicrobial UTI as 307 
Enterococcus is known to be intrinsically resistant to many antibiotics, including 308 
several first choice antibiotics for the treatment of UTI. The presence of both this 309 
organism and uropathogenic E. coli in an infection may not only create difficulties 310 
in devising an antibiotic treatment regimen but also recent studies have 311 
suggested E. faecalis may exacerbate the pathogenicity of E. coli (Lavigne et al., 312 
2008, & Montravers et al., 1997).  313 
Prescription of ineffective antibacterial agents can increase selection pressure for 314 
antibiotic resistant agents within an infection. Organisms present in polymicrobial 315 
UTI cultures, that would not routinely be investigated, possessed antibiotic 316 
resistance to front line antibiotics such as trimethoprim, ciprofloxacin and 317 
amoxicillin. More importantly the percentage of mixed culture sample E. coli 318 
isolates exhibiting resistance to trimethoprim and ciprofloxacin was higher than 319 
that observed in monomicrobial culture sample isolates, and also higher than the 320 
levels observed routinely in clinical isolates. Another issue raising concerns for 321 
patient health is the presence of MRSA and PVL-producing MSSA in 322 
polymicrobial UTI samples, which would not be detected under the current 323 
guidelines for UTI diagnosis.  The presence of MRSA in an infection limits the 324 
choice of antibiotics available for treatment, and the cytotoxin PVL attacks white 325 
blood cells and can cause severe tissue necrosis (Holmes et al., 2005). Other 326 
specific antibiotic resistance traits such as extended-spectrum β-lactamases 327 
were also detected, by PCR for known β-lactamase genes, although only a small 328 
proportion showed phenotypic activity. This discrepancy re-emphasises the 329 
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importance of screening clinical isolates for ESBL gene carriage as opposed to 330 
phenotypic tests (Livermore & Hawkey, 2005, Tofteland et al., 2007, & Xu et al., 331 
2005). Interestingly, the current increase in isolation of E. coli 025b-ST131 CTX-332 
MR from clinical samples (Lau et al., 2008, Nicolas-Chanoine et al., 2008, & 333 
Vincent et al., 2010) does not appear to be reflected in this study, with only 11% 334 
of E. coli containing the blaCTX-M gene. The full genetic diversity and lineage of the 335 
ExPEC strains isolated in this study is the current focus of intensive research.   336 
It has been suggested that the critical step in UTI initiation is the attachment to 337 
and invasion of the superficial bladder epithelium, especially in the case of E. coli 338 
(Anderson et al., 2003, & Mulvey et al., 2001). By attaching to bladder epithelial 339 
cells E. coli are able to establish reservoirs known as intra-cellular bacterial 340 
communities, from which the invading bacteria receive some level of protection 341 
against the host immune system and also initiate recurrent infections. Therefore 342 
invasive bacteria are considered more proficient in instigating an infection. 343 
Significant differences were identified in the invasive capabilities of 344 
monomicrobial culture and polymicrobial culture isolates (figure 3). E. coli isolates 345 
of polymicrobial culture origin were significantly more invasive when compared to 346 
the invasion of the type strain, E. coli CFT073, than strains isolated from 347 
monomicrobial culture samples. The majority of isolates from monomicrobial 348 
infections were less invasive than E. coli CFT073 and none exhibited a highly 349 
invasive phenotype. The polymicrobial isolates that possessed increased 350 
invasive capacity did not belong exclusively to any specific patient group and 351 
were not shown to be associated with patient gender, catheterisation status, 352 
previous history of UTI and underlying medical issues, antibiotic resistance profile 353 
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or BOX-PCR group. This indicates the potential existence of a heterogeneous 354 
group of highly invasive E. coli within polymicrobial UTI in the elderly, which 355 
would not be diagnosed or treated due to limitations in the current diagnostic 356 
standard procedure. A further study including larger numbers of ExPEC isolates 357 
from monomicrobial infections is required to rule out any such associations, and 358 
indeed to confirm the significance of the increased invasive phenotype 359 
exclusively observed in the polymicrobial isolates from this study. This is 360 
currently under investigation in several hospital labs examining equal numbers of 361 
polymicrobial and monomicrobial isolates, including an examination of the clinical 362 
nature of the infections, their association with complicated or uncomplicated UTI, 363 
and the genotypic and phenotypic differences associated with the hyper-invasive 364 
phenotype.  365 
The frequent co-isolation of E. coli and E. faecalis from the clinical UTI samples 366 
raises questions as to the possible contribution of Enterococci to the increased 367 
invasive phenotype expressed by the ExPEC strains isolated in this study. There 368 
have been reports of Enterococci exacerbating the pathogenicity of other 369 
organisms including ExPEC in both C. elegans and rat models of infection 370 
(Lavigne et al., 2008, & Montravers et al., 1997), and the promiscuous nature of 371 
Enterococci with regards to gene transfer is well known. The possibility that 372 
Enterococci can alter the genotype and/or phenotype of ExPEC during co-373 
infection of bladder epithelial cells is currently the subject of further investigation. 374 
Polymicrobial urinary tract infections may pose a heightened threat to the health 375 
and well being of the elderly population.  This study found that the organisms 376 
present in polymicrobial UTI possess traits such as antibiotic resistance akin to 377 
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that of their monomicrobial culture counterparts, and potentially with increased 378 
resistance to ciprofloxacin and trimethoprim which common front line antibiotics 379 
used for UTI treatment. Due to the complexities involved in the diagnosis and 380 
treatment in these infections many patients may receive inadequate antibiotic 381 
treatment or indeed a lack of treatment altogether. More worryingly for patient 382 
health, the majority of organisms isolated from polymicrobial cultures also 383 
exhibited increased human pathogenic potential as evidenced by in vitro cell 384 
infection assays. The diagnostic standard procedure for UTI should be 385 
reconsidered in light of the data presented here.   386 
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Table 1. Prevalence of antibiotic resistance in UTI isolates 
Antibiotic 
concentration 
(µg/ml) 
E. coli (%) E. faecalis  (%) P. mirabilis  (%) S. aureus  (%) 
P. aeruginosa  
(%) 
Poly 
(n=129) 
Mono 
(n=21) 
Poly 
(n=110
) 
Mono 
(n=4) 
Poly 
(n=56) 
Mono 
(n=1) 
Poly 
(n=18) 
Mon
o 
(n=4) 
Poly 
(n=46) 
Mono 
(n=5) 
Gentamicin (2) 12.4 4.76 - - 5.3 0.0 4.5 0 - - 
Cefotaxime (1) 17.8 14.29 - - 33.9 100.0 - - - - 
Ceftazidime (1) 18.6 9.52 - - 35.7 100.0 - - - - 
Meropenem (2) 0.0 0.00 15.5 0.0 0.0 0.0 - - - - 
Piperacillin-
Tazobactam (16) 
6.2 4.76 4.5 25.0 23.2 100.0 - - - - 
Co-amoxiclav 
(32) 
5.4 0.00 2.7 0.0 16.1 100.0 0.0 0.0 - - 
Trimethoprim (2) 44.2 28.57 - - 89.0 0.0 22.2 0.0 - - 
Ciprofloxacin (4) 23.3 9.52 28.2 0.0 0.0 0.0 55.5 50.0 - - 
Cephradine (32) 28.7 19.05 - - 55.3 100.0 50.0 25.0 - - 
Nitrofurantoin 
(32) 
17.1 9.52 10.9 0.0   11.0 0.0 - - 
Amoxicillin (32) 45.0 42.86 7.3 0.0 37.5 100.0 66.6 75.0 - - 
Gentamicin (10) - - - - - - - - 2.17 0.0 
Piperacillin-
tazobactam (85) 
- - - - - - - - 0.0 0.0 
Ceftazidime (30) - - - - - - - - 2.17 00.0 
Meropenem (10) - - - - - - - - 2.17 0.0 
Ciprofloxacin (1) - - - - - - - - 4.35 00.0 
25 
NOTE ‘-‘ indicates that particular species/antibiotic combination was not tested. 
The term ‘poly’ refers to strains of polymicrobial infection origin, whilst the term 
‘mono’ refers to strains of monomicrobial infection origin. 
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Table 2. β-lactamase gene carriage in UTI isolates as determined by PCR 
 
β-Lactamase carriage 
Percentage 
of strains 
Any  
β-lactamase 
- monomicrobial culture 
isolates  
57.1 
- polymicrobial isolates  48.4 
   
SHV 
- monomicrobial culture 
isolates  
8.6 
- polymicrobial isolates  9.8 
   
TEM 
- monomicrobial culture 
isolates  
45.7 
- polymicrobial isolates  36.4 
   
CTX-M 
- monomicrobial culture 
isolates  
22.9* 
- polymicrobial isolates  9.5 
   
OXA 
- monomicrobial culture 
isolates  
11.4 
- polymicrobial isolates  4.7 
   
Multiple  
β-lactamases 
- monomicrobial culture 
isolates  
22.9# 
- polymicrobial isolates  8.8 
27 
Strains tested were all  E.. coli, Pseudomonas spp, Proteus spp, Citrobacter spp, 
Enterobacter spp and Klebsiella spp isolated in this study. * P=0.016, #P=0.01, χ 
2
 test.  
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Figure 1.The relative prevalence of each of the main species associated with UTI 
isolated from the different types of sample collected in the study. Prevalence is 
presented as the percentage of samples collected which contain the given 
species. 
* Indicates cultures taken from polymicrobial infections 
 
 
 
Figure 2. BOX-PCR gel of E. coli strains isolated from UTI samples 
Lanes marked * contain the BOX-PCR profile for Escherichia coli CFT073, lanes 
marked M contain molecular weight markers. Remaining lanes show a selection 
of BOX profiles obtained for E. coli isolates. 
 
 
Figure 3.  Invasive capabilities of UTI E. coli isolates compared to E. coli 
CFT073. CFT073 invasion is designated as 1.00. Polymicrobial sample isolates 
are statistically more invasive than monomicrobial culture sample isolates, 
P<0.001, χ2 test. 
